Group of antimicrobial agents | Symbol (Oxoid) | Antimicrobial | Concentration (μg) |
---|---|---|---|
Sulfonamides | S3 | compound sulfonamides | 300 |
SXT | sulphamethoxazole/trimethoprim | 23.75/1.25 | |
Quinolones | OA | oxolinic acid | 2 |
UB | flumequine | 30 | |
ENR | enrofloxacin | 5 | |
Tetracycline | OT | oxytetracycline | 30 |
Phenicols | FFC | florfenicol | 30 |
Inhibition zone diameter (IZD), mm | |
---|---|
High susceptibility, IZD ≥ 15 mm | |
23.75 ± 1.64 | |
15.25 ± 0.90 | |
15.31 ± 1.01 | |
18.81 ± 1.25 | |
18.31 ± 1.13 | |
17.63 ± 0.92 | |
25.56 ± 1.63 | |
19.38 ± 1.27 | |
18.56 ± 1.29 | |
20.25 ± 1.06 | |
17.63 ± 1.07 | |
15.19 ± 0.84 | |
22.5 ± 1.20 | |
20.63 ± 1.44 | |
Intermediate susceptibility, IZD = 10–15 mm | |
14.5 ± 0.94 | |
12.5 ± 0.80 | |
12.38 ± 0.82 | |
14.19 ± 0.82 | |
12.38 ± 0.83 | |
13.5 ± 0.76 | |
14.44 ± 0.85 | |
13.38 ± 0.82 | |
14.25 ± 0.80 | |
Resistance, IZD ≤ 10 mm | |
9.25 ± 0.53 | |
9.5 ± 0.54 | |
9.75 ± 0.60 | |
9.19 ± 0.55 | |
9.5 ± 0.33 | |
9.5 ± 0.62 | |
9.63 ± 0.50 | |
9.62 ± 0.67 | |
9.38 ± 0.62 | |
9.5 ± 0.62 | |
9.75 ± 0.64 | |
9.25 ± 0.45 | |
9.88 ± 0.52 | |
9.56 ± 0.65 | |
9.5 ± 0.77 | |
9.75 ± 0.53 | |
9.56 ± 0.59 | |
9.63 ± 0.65 |
Inhibition zone diameter (IZD), mm | |
---|---|
High susceptibility, IZD ≥ 15 mm | |
20.63 ± 1.45 | |
17.25 ± 1.10 | |
16.06 ± 1.05 | |
17.5 ± 1.27 | |
15.25 ± 1.05 | |
21.25 ± 1.33 | |
15.19 ± 0.80 | |
22.56 ± 1.66 | |
15.06 ± 0.83 | |
25.44 ± 1.35 | |
Intermediate susceptibility, IZD = 10–15 mm | |
13.38 ± 0.68 | |
11.5 ± 0.76 | |
11.25 ± 0.37 | |
13.75 ± 0.86 | |
12.38 ± 0.82 | |
14.13 ± 0.69 | |
12.25 ± 0.65 | |
10.88 ± 0.58 | |
13.13 ± 0.91 | |
11.38 ± 0.60 | |
13.0 ± 0.94 | |
Resistance, IZD ≤ 10 mm | |
9.31 ± 0.73 | |
9.63 ± 0.63 | |
9.13 ± 0.69 | |
9.5 ± 0.77 | |
9.5 ± 0.62 | |
9.38 ± 0.6 | |
9.5 ± 0.6 | |
9.06 ± 0.71 | |
9.38 ± 0.38 | |
9.13 ± 0.6 | |
9.38 ± 0.42 | |
9.5 ± 0.67 | |
9.31 ± 0.52 | |
9.44 ± 0.76 | |
9.45 ± 0.8 | |
9.48 ± 0.47 | |
9.5 ± 0.47 | |
9.69 ± 0.62 | |
9.75 ± 0.37 | |
9.63 ± 0.67 |
Inhibition zone diameter (IZD), mm | |
---|---|
High susceptibility, IZD ≥ 15 mm | |
20.0 ± 0.53 | |
15.75 ± 0.80 | |
15.25 ± 1.15 | |
20.13 ± 0.79 | |
18.88 ± 0.48 | |
17.75 ± 0.53 | |
20.63 ± 0.71 | |
20.64 ± 1.16 | |
17.88 ± 0.74 | |
15.25 ± 0.82 | |
17.38 ± 0.68 | |
20.5 ± 0.77 | |
20.63 ± 0.53 | |
Intermediate susceptibility, IZD = 10–15 mm | |
12.25 ± 0.73 | |
12.5 ± 0.57 | |
12.38 ± 0.53 | |
13.63 ± 0.89 | |
13.75 ± 0.62 | |
12.63 ± 0.50 | |
11.25 ± 1.16 | |
12.13 ± 0.44 | |
10.38 ± 0.32 | |
10.19 ± 0.52 14.75 ± 0.92 | |
14.25 ± 1.05 | |
14.13 ± 1.11 | |
12.13 ± 0.88 | |
13.38 ± 0.42 | |
Resistance, IZD ≤ 10 mm | |
9.25 ± 0.41 | |
9.13 ± 0.35 | |
9.63 ± 0.91 | |
9.38 ± 0.53 | |
9.5 ± 0.5 | |
9.38 ± 0.65 | |
9.25 ± 0.31 | |
9.25 ± 0.65 | |
9.38 ± 0.56 | |
9.25 ± 0.59 | |
9.38 ± 0.42 | |
8.88 ± 0.48 | |
9.5 ± 0.65 |
Inhibition zone diameter (IZD), mm |
|||||||
---|---|---|---|---|---|---|---|
Strains | S3 | SXT | OA | UB | ENR | OT | FFC |
6.37 ± 0.28 | 30 ± 1.8 | 32.86 ± 1.44 | 35.29 ± 1.61 | 35.14 ± 1.52 | 29.14 ± 1.56 | 35 ± 0.98 | |
14.86 ± 0.91 | 24.14 ± 2.53 | 30.14 ± 1.24 | 30.57 ± 0.37 | 27.43 ± 1.45 | 23.43 ± 1.19 | 24.14 ± 0.88 | |
6.43 ± 0.30 | 25.14 ± 1.28 | 31.0 ± 0.9 | 32.86 ± 1.08 | 35.14 ± 1.83 | 27.0 ± 1.0 | 35.29 ± 1.11 | |
subsp. |